Swiss National Bank’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.51M | Hold |
250,900
| – | – | ﹤0.01% | 1474 |
|
|
2025
Q1 | $3.41M | Sell |
250,900
-2,600
| -1% | -$35.3K | ﹤0.01% | 1475 |
|
|
2024
Q4 | $5.17M | Buy |
253,500
+2,800
| +1% | +$57.1K | ﹤0.01% | 1317 |
|
|
2024
Q3 | $7.3M | Buy |
250,700
+17,900
| +8% | +$521K | ﹤0.01% | 1094 |
|
|
2024
Q2 | $5.41M | Buy |
232,800
+14,600
| +7% | +$339K | ﹤0.01% | 1224 |
|
|
2024
Q1 | $4.48M | Buy |
218,200
+1,500
| +0.7% | +$30.8K | ﹤0.01% | 1362 |
|
|
2023
Q4 | $4.65M | Sell |
216,700
-24,100
| -10% | -$517K | ﹤0.01% | 1338 |
|
|
2023
Q3 | $4.97M | Buy |
240,800
+2,700
| +1% | +$55.7K | ﹤0.01% | 1283 |
|
|
2023
Q2 | $7.03M | Buy |
238,100
+32,900
| +16% | +$971K | ﹤0.01% | 1105 |
|
|
2023
Q1 | $4.73M | Sell |
205,200
-3,300
| -2% | -$76K | ﹤0.01% | 1314 |
|
|
2022
Q4 | $5.8M | Buy |
208,500
+4,400
| +2% | +$122K | ﹤0.01% | 1223 |
|
|
2022
Q3 | $6.26M | Buy |
204,100
+2,700
| +1% | +$82.9K | ﹤0.01% | 1147 |
|
|
2022
Q2 | $5.93M | Buy |
201,400
+13,700
| +7% | +$403K | ﹤0.01% | 1218 |
|
|
2022
Q1 | $6.04M | Buy |
187,700
+14,000
| +8% | +$450K | ﹤0.01% | 1329 |
|
|
2021
Q4 | $7.75M | Sell |
173,700
-400
| -0.2% | -$17.8K | ﹤0.01% | 1169 |
|
|
2021
Q3 | $8.78M | Buy |
174,100
+2,300
| +1% | +$116K | 0.01% | 1067 |
|
|
2021
Q2 | $13.5M | Sell |
171,800
-6,300
| -4% | -$494K | 0.01% | 862 |
|
|
2021
Q1 | $10.2M | Buy |
178,100
+3,300
| +2% | +$188K | 0.01% | 994 |
|
|
2020
Q4 | $14.6M | Sell |
174,800
-4,800
| -3% | -$402K | 0.01% | 754 |
|
|
2020
Q3 | $6.44M | Buy |
179,600
+3,100
| +2% | +$111K | 0.01% | 1021 |
|
|
2020
Q2 | $4.27M | Buy |
176,500
+55,400
| +46% | +$1.34M | ﹤0.01% | 1236 |
|
|
2020
Q1 | $2.12M | Buy |
121,100
+1,800
| +2% | +$31.5K | ﹤0.01% | 1422 |
|
|
2019
Q4 | $2.08M | Buy |
119,300
+3,000
| +3% | +$52.3K | ﹤0.01% | 1713 |
|
|
2019
Q3 | $1.78M | Buy |
116,300
+1,500
| +1% | +$23K | ﹤0.01% | 1740 |
|
|
2019
Q2 | $2.38M | Buy |
114,800
+2,300
| +2% | +$47.7K | ﹤0.01% | 1584 |
|
|
2019
Q1 | $2.61M | Buy |
112,500
+3,500
| +3% | +$81.3K | ﹤0.01% | 1488 |
|
|
2018
Q4 | $2.25M | Buy |
109,000
+1,900
| +2% | +$39.3K | ﹤0.01% | 1488 |
|
|
2018
Q3 | $2.33M | Buy |
107,100
+74,200
| +226% | +$1.61M | ﹤0.01% | 1622 |
|
|
2018
Q2 | $502K | Buy |
+32,900
| New | +$502K | ﹤0.01% | 2444 |
|